…
Carclo plc, together with its subsidiaries, provides plastic components for the life sciences, aerospace, and advanced industries in the United Kingdom, France, the Czech Republic, China, India, rest of Europe, North America, and internationally. It operates through two segments, CTP and Speciality. The company offers in vitro diagnostics and medical devices, including microfluidic, pipettes, cuvettes, multiwells, and capillary blood sampling devices; drug delivery products comprising inhaler systems and auto injector pens; and injection moulded components for ATM cash storage and dispensing systems, lighting control, and electronics and megatronics. It also provides design and engineering solutions consisting of validation, automation, and education services; and manufacturing services, which include injection moulding, assembly and welding, decoration, and supply chain solutions. In addition, the company offers aerospace mechanical cable assemblies and machined components under the Bruntons and Jacottet brands; speciality optics; and fresnel lenses. Carclo plc was incorporated in 1924 and is headquartered in Mitcham, the United Kingdom.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Income before tax | 2.65M | -3.80M | -2.52M | 5.92M | 6.67M |
| Minority interest | - | 0.00M | 0.00M | 0.00M | -0.03M |
| Net income | 0.87M | -3.30M | -3.96M | 5.80M | 7.41M |
| Selling general administrative | 1.73M | 1.46M | 0.41M | 0.28M | 0.33M |
| Selling and marketing expenses | 38.06M | 40.42M | - | - | - |
| Gross profit | 73.54M | 72.10M | 74.60M | 69.87M | 62.62M |
| Reconciled depreciation | 6.54M | 7.93M | 8.03M | 7.03M | 5.98M |
| Ebit | 8.15M | 2.21M | 6.16M | 6.17M | 9.37M |
| Ebitda | 14.69M | 10.15M | 14.18M | 13.20M | 15.35M |
| Depreciation and amortization | 6.54M | 7.93M | 8.03M | 7.03M | 5.98M |
| Operating income | 7.58M | 1.79M | 1.23M | 8.90M | 9.33M |
| Other operating expenses | 113.64M | 130.88M | 137.51M | 122.48M | 101.97M |
| Interest expense | 5.50M | 6.01M | 3.97M | 3.07M | 2.70M |
| Tax provision | 1.78M | -0.50M | 1.44M | 0.81M | 0.46M |
| Interest income | 0.57M | 0.42M | 0.22M | 0.08M | 0.04M |
| Net interest income | -4.93M | -5.59M | -3.75M | -2.99M | -2.66M |
| Income tax expense | 1.78M | -0.50M | 1.44M | 0.81M | 0.46M |
| Total revenue | 121.22M | 132.67M | 143.44M | 128.58M | 107.56M |
| Total operating expenses | 65.96M | 70.31M | 137.51M | 122.48M | 57.02M |
| Cost of revenue | 47.68M | 60.57M | 68.85M | 58.70M | 44.94M |
| Total other income expense net | -4.93M | -5.59M | -6.88M | 0.33M | 1.93M |
| Discontinued operations | - | - | - | 0.69M | 1.20M |
| Net income from continuing ops | 0.87M | -3.30M | -3.96M | 5.11M | 6.21M |
| Net income applicable to common shares | - | - | - | 5.80M | 7.41M |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Total assets | 97.03M | 100.94M | 122.67M | 128.20M | 116.02M |
| Intangible assets | 0.13M | 0.17M | 0.45M | 0.75M | 0.78M |
| Other current assets | 3.87M | 3.40M | 27.67M | 27.67M | 22.15M |
| Total liab | 108.88M | 97.28M | 111.07M | 103.78M | 108.11M |
| Total stockholder equity | -11.81M | 3.69M | 11.63M | 24.44M | 7.94M |
| Other current liab | 11.91M | 10.11M | 18.90M | 14.62M | 18.96M |
| Common stock | 3.67M | 3.67M | 3.67M | 3.67M | 3.67M |
| Capital stock | 3.67M | 3.67M | 3.67M | 3.67M | 3.67M |
| Retained earnings | -29.49M | -14.56M | -8.64M | 5.93M | -8.43M |
| Other liab | - | - | - | 33.96M | 42.53M |
| Good will | 21.67M | 22.03M | 23.01M | 21.96M | 21.07M |
| Other assets | - | - | - | 1.52M | 0.50M |
| Cash | 10.74M | 5.97M | 10.35M | 12.35M | 15.48M |
| Total current liabilities | 48.01M | 28.53M | 31.99M | 28.02M | 27.58M |
| Current deferred revenue | - | 3.00M | -13.37M | -10.61M | -13.49M |
| Net debt | 19.20M | 29.46M | 34.36M | 32.41M | 27.60M |
| Short term debt | 24.84M | 11.23M | 5.05M | 2.95M | 5.08M |
| Short long term debt | 22.09M | 6.85M | 1.34M | 1.40M | 5.08M |
| Short long term debt total | 29.95M | 39.91M | 44.71M | 44.75M | 43.08M |
| Other stockholder equity | 7.36M | 7.36M | 4.97M | -9.60M | 4.75M |
| Property plant equipment | - | - | - | 46.96M | 43.22M |
| Total current assets | 37.99M | 37.81M | 52.70M | 57.00M | 50.46M |
| Net tangible assets | - | - | - | 1.73M | -13.91M |
| Net receivables | 13.45M | 17.15M | 21.38M | 27.40M | 22.15M |
| Long term debt | 0.10M | 21.89M | 31.50M | 32.48M | 32.41M |
| Inventory | 9.93M | 11.29M | 15.20M | 16.99M | 12.82M |
| Accounts payable | 9.70M | 9.70M | 21.41M | 21.06M | 17.02M |
| Accumulated other comprehensive income | 6.65M | 7.22M | - | - | - |
| Common stock total equity | - | - | - | - | 3.67M |
| Non currrent assets other | - | 0.17M | -68.78M | -69.68M | -65.07M |
| Non current assets total | 59.05M | 63.13M | 69.97M | 71.20M | 65.56M |
| Capital lease obligations | 7.77M | 11.17M | 11.87M | 10.87M | 7.05M |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Investments | -0.45M | -2.40M | -0.81M | -4.15M | -6.01M |
| Change to liabilities | - | - | - | 4.89M | 4.71M |
| Total cashflows from investing activities | -0.45M | -2.40M | - | -4.15M | -6.01M |
| Net borrowings | -2.62M | -8.38M | - | -2.49M | 5.43M |
| Total cash from financing activities | -7.00M | -12.14M | -4.67M | -2.49M | 5.05M |
| Net income | 0.87M | -3.30M | -3.96M | 5.80M | 7.41M |
| Change in cash | 4.01M | -4.38M | -1.99M | -3.14M | 7.13M |
| Begin period cash flow | 5.97M | 10.35M | 12.35M | 15.48M | 8.35M |
| End period cash flow | 9.98M | 5.97M | 10.35M | 12.35M | 15.48M |
| Total cash from operating activities | 11.48M | 10.37M | 3.77M | 2.97M | 8.40M |
| Depreciation | 6.54M | 7.93M | 8.03M | 7.03M | 5.98M |
| Other cashflows from investing activities | 0.61M | 0.54M | - | 0.77M | 1.29M |
| Change to inventory | 1.31M | 3.43M | 1.54M | -3.82M | 0.77M |
| Change to account receivables | 2.18M | 6.11M | 0.73M | -4.67M | -1.80M |
| Other cashflows from financing activities | -4.38M | -3.76M | -2.77M | -0.21M | 36.72M |
| Change to netincome | - | - | - | -6.26M | -8.67M |
| Capital expenditures | 1.10M | 2.94M | 2.42M | 4.94M | 7.32M |
| Change in working capital | 5.76M | 4.62M | -1.21M | -3.60M | 3.68M |
| Stock based compensation | 0.03M | 0.05M | -0.03M | 0.07M | 0.00M |
| Other non cash items | -1.73M | 1.07M | 7.00M | 0.05M | -3.80M |
| Free cash flow | 10.38M | 7.43M | 1.35M | -1.97M | 1.08M |
Sector: Consumer Cyclical Industry: Auto Parts
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CAR Carclo plc |
0.20 0.50% |
40.20 | 15.78 | 6.25 | 0.30 | 1.92 | 0.50 | 3.49 |
| DCH DAUCH CORP |
4.00 1.15% |
352.00 | - | 26.74 | 0.18 | 2.21 | 0.84 | 7.42 |
| ABDP Ab Dynamics |
4.00 0.50% |
804.00 | 21.27 | 13.02 | 2.21 | 1.69 | 1.70 | 7.61 |
| AURR Aurrigo International PLC |
-1.50 1.27% |
117.00 | - | - | 8.65 | 7.71 | 8.46 | -11.87 |
| PWR POWER PROBE PLC ORD 0.1P |
0.50 0.89% |
56.50 | 9.25 | - | 1.48 | 9.71 | 2.01 | 8.01 |
Carclo plc, together with its subsidiaries, provides plastic components for the life sciences, aerospace, and advanced industries in the United Kingdom, France, the Czech Republic, China, India, rest of Europe, North America, and internationally. It operates through two segments, CTP and Speciality. The company offers in vitro diagnostics and medical devices, including microfluidic, pipettes, cuvettes, multiwells, and capillary blood sampling devices; drug delivery products comprising inhaler systems and auto injector pens; and injection moulded components for ATM cash storage and dispensing systems, lighting control, and electronics and megatronics. It also provides design and engineering solutions consisting of validation, automation, and education services; and manufacturing services, which include injection moulding, assembly and welding, decoration, and supply chain solutions. In addition, the company offers aerospace mechanical cable assemblies and machined components under the Bruntons and Jacottet brands; speciality optics; and fresnel lenses. Carclo plc was incorporated in 1924 and is headquartered in Mitcham, the United Kingdom.
| Name | Title | Year Born |
|---|---|---|
| Mr. Frank Doorenbosch | CEO & Exec. Director | NA |
| Mr. Phil White | Exec. Officer | NA |
| Mr. David Michael Bedford | CFO & Director | 1969 |
| Mr. Stephen Nixon | Interim Group Chief Operating Officer | NA |
| Mr. Christopher J. Malley | LED Technologies Divisional Chief Exec. | 1967 |
| Ms. Angie Wakes | Group Company Sec. | NA |
| Mr. Franciscus Lodewijk Paulus Doorenbosch | CEO & Executive Director | 1964 |
| Gary Allan | Chief Operating Officer | NA |
| Ms. Florentina Andronovici | Head of Legal | NA |
| Mr. Alan Hook | Managing Director of Bruntons | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.